CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients (Q73146352)
Jump to navigation
Jump to search
scientific article published on 01 March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients |
scientific article published on 01 March 2003 |
Statements
CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients (English)
Jean-Philippe Dales
Stephane Garcia
Pascal Bonnier
Florence Duffaud
Lucile Andrac-Meyer
Olivier Ramuz
Marie-Noëlle Lavaut
Claude Allasia